Ignite Creation Date:
2024-05-06 @ 8:07 PM
Last Modification Date:
2024-10-26 @ 3:20 PM
Study NCT ID:
NCT06251180
Status:
RECRUITING
Last Update Posted:
2024-04-16
First Post:
2024-02-01
Brief Title:
Phase Ib Study of Rocbrutinib in Combination With R-CHOP in Patients With Newly Diagnosed B-cell Non-Hodgkin Lymphoma
Sponsor:
Guangzhou Lupeng Pharmaceutical Company LTD
Organization:
Guangzhou Lupeng Pharmaceutical Company LTD
Conditions & Keywords Data
Conditions:
| Name |
|---|
| B-cell Non-Hodgkin Lymphoma |
Keywords: